Adenocarcinoma prostático metastásico, a propósito de un caso
DOI:
https://doi.org/10.51581/rccm.v27i1.158Palabras clave:
Próstata, adenocarcinoma, metástasis, vejiga urinaria, neoplasias de la próstataResumen
El adenocarcinoma prostático metastásico es una forma avanzada de cáncer de próstata que presenta complicacionesclínicassignificativas,especialmentecuandosediseminaalacolumnavertebralylavejiga.Esta progresión puede causar dolor intenso, pérdida de función neurológica y problemas urinarios. Este estudio revisa un caso de un paciente de 68 años con adenocarcinoma prostático metastásico que presentó síntomas como dolor lumbar, hematuria, impactación fecal y problemas neurológicos. Se realizaron estudios de imagen como Tomografía Axial Computarizada (TAC) y Resonancia Magnética (RMN), junto con biopsia e inmunohistoquímica, para confirmar el diagnóstico. El tratamiento incluyó radioterapia y bloqueo androgénico. El paciente desarrolló infiltración tumoral en T11 y tejidos blandos, y, aunque se ajustó la radioterapia, el PSA total siguió en aumento. Además, se identificó carcinoma urotelial metastásico en la vejiga. El manejo de estos casos requiere un enfoque multidisciplinario para controlar la expansión metastásica y sus efectos debilitantes.
Métricas
Citas
Chohan MO, Kahn S, Cederquist G, Reiner AS, Schwab J, Laufer I, et al. Surgical decompression of high-grade spinal cord compression from hormone refractory metastatic prostate cancer. Neurosurgery [Internet]. 2018 [cited 2024 Sep 15];82(5):670– 7. Available from: https://pubmed.ncbi.nlm. nih.gov/28541420/ DOI: https://doi.org/10.1093/neuros/nyx292
Majmundar N, Shao B, Assina R. Lung adenocarcinoma presenting as intramedullary spinal cord metastasis: Case report and review of literature. J Clin Neurosci [Internet]. 2018 [cited 2024 Sep 15];52:124–31. Available from: https://pubmed.ncbi.nlm.nih.gov/29631755/ DOI: https://doi.org/10.1016/j.jocn.2018.03.030
Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate Cancer, version 4.2023, NCCN clinical practice Guidelines in oncology. J Natl Compr Canc Netw [Internet]. 2023 [cited 2024 Sep 15];21(10):1067–96. Available from: https:// pubmed.ncbi.nlm.nih.gov/37856213/
Bourefis A, Berredjem H, Djeffal O, Le TK, Giusiano S, Rocchi P. HSP27/Menin expression as new prognostic serum biomarkers of prostate cancer aggressiveness independent of PSA. Cancers (Basel) [Internet]. 2022 [cited 2024 Sep 15];14(19):4773. Available from: https://pubmed.ncbi.nlm.nih.gov/36230697/ DOI: https://doi.org/10.3390/cancers14194773
Yu E-M, Aragon-Ching JB. Advances with androgen deprivation therapy for prostate cancer. Expert Opin Pharmacother [Internet]. 2022 [cited 2024 Sep 15];23(9):1015–33. DOI: https://doi.org/10.1080/14656566.2022.2033210
Available from: https://pubmed.ncbi.nlm.nih. gov/35108137/
Shapiro CL, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R, et al. Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline. J Clin Oncol [Internet]. 2019 [cited 2024 Sep 15];37(31):2916–46. Available from: https://pubmed.ncbi.nlm.nih. gov/31532726/ DOI: https://doi.org/10.1200/JCO.19.01696
Lin X, Shi Q, Yang XJ. Cytomorphology, immunoprofile, and clinicopathologic correlation of metastatic prostatic carcinoma. Hum Pathol [Internet]. 2022 [cited 2024 Sep 15];130:36–46. Available from: https:// pubmed.ncbi.nlm.nih.gov/36244466/ DOI: https://doi.org/10.1016/j.humpath.2022.10.007
Dum D, Menz A, Völkel C, De Wispelaere N, Hinsch A, Gorbokon N, et al. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. Exp Mol Pathol [Internet]. 2022;126(104762):104762. Available from: http://dx.doi.org/10.1016/j. yexmp.2022.104762 DOI: https://doi.org/10.1016/j.yexmp.2022.104762
Li H, Ma Z, Che Z, Li Q, Fan J, Zhou Z, et al. Comprehensive role of prostate‐specific antigen identified with proteomic analysis in prostate cancer. J Cell Mol Med [Internet]. 2020 [cited 2024 Sep 15];24(17):10202–15. Available from: https://pubmed.ncbi.nlm.nih. gov/33107155/ DOI: https://doi.org/10.1111/jcmm.15634
Guan L, Zhao X, Tang L, Chen J, Zhao J, Guo M, et al. Thyroid transcription factor-1: Structure, expression, function and its relationship with disease. Biomed Res Int [Internet]. 2021 [cited 2024 Sep 15];2021:1–10. Available from: https://pubmed.ncbi.nlm.nih. gov/34631891/ DOI: https://doi.org/10.1155/2021/9957209
Bai J, Grant K, Hussien A, Kawakyu- O’Connor D. Imaging of metastatic epidural spinal cord compression. Front Radiol [Internet]. 2022 [cited 2024 Sep 15];2. Available from: https://pubmed.ncbi.nlm.nih. gov/37492671/ DOI: https://doi.org/10.3389/fradi.2022.962797
Trabulsi EJ, Rumble RB, Jadvar H, Hope T, Pomper M, Turkbey B, et al. Optimum imaging strategies for advanced prostate cancer: ASCO guideline. J Clin Oncol [Internet]. 2020 [cited 2024 Sep 15];38(17):1963–96. Available from: https://pubmed.ncbi.nlm.nih.gov/31940221/
WangH,XieD,LuJ,ChuY,WangS,Qiao P, et al. Case Report: Analysis of four cases of metastatic bladder masses after radical
prostatectomy. Front Oncol [Internet]. 2023 [cited 2024 Sep 15];13. Available from: https:// pubmed.ncbi.nlm.nih.gov/37576903/
Virgo KS, Rumble RB, Talcott J. Initial management of noncastrate advanced, recurrent, or metastatic prostate cancer: ASCO guideline update. J Clin Oncol [Internet]. 2023 [cited 2024 Sep 15];41(20):3652–6. Available from: https://pubmed.ncbi.nlm.nih. gov/37011338/ DOI: https://doi.org/10.1200/JCO.23.00155
Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, et al. External beam radiotherapy increases the risk of bladder cancer when compared with radical prostatectomy in patients affected by prostate cancer: A population-based analysis. Eur Urol [Internet]. 2019 [cited 2024 Sep 15];75(2):319– 28. Available from: https://pubmed.ncbi.nlm. nih.gov/30293908/ DOI: https://doi.org/10.1016/j.eururo.2018.11.024
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Revista Cientifica Ciencia Medica
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
